Sangamo Therapeutics Reports Recent Business Highlights and First Quarter 2021 Financial Results

Go back to Sangamo Therapeutics Reports Recent Business Highlights and First Quarter 2021 Financial Results
Sangamo Biosciences, Inc. (NASDAQ: SGMO) Delayed: 0.18 --0 (-0%)
Previous Close $0.18    52 Week High $9.91 
Open $0.18    52 Week Low $3.10 
Day High $0.18    P/E N/A 
Day Low $0.18    EPS $-0.48 
Volume 109